SAN DIEGO, Aug. 10 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD - News) today disclosed that researchers have initiated testing of its Hemopurifier® as a candidate treatment against the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The device has been designed to enhance the benefit of antiviral drug regimens, and it provides a therapeutic option against infectious viruses not addressed by drug and vaccine therapies.
